Pharus Diagnostics Signs Worldwide Exclusive License Agreement with City of Hope for Novel Biomarkers to Be Used in Liquid Biopsy Screening for Early Pancreatic Cancer Diagnosis ...Middle East

LOS ANGELES, Feb. 15, 2024 /PRNewswire/ -- Pharus Diagnostics ("PharusDx") today announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be used in early screening of individuals at risk for pancreatic ductal adenocarcinoma (PDAC). This...

Hence then, the article about pharus diagnostics signs worldwide exclusive license agreement with city of hope for novel biomarkers to be used in liquid biopsy screening for early pancreatic cancer diagnosis was published today ( Thursday 15/02/2024 - 10:48 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pharus Diagnostics Signs Worldwide Exclusive License Agreement with City of Hope for Novel Biomarkers to Be Used in Liquid Biopsy Screening for Early Pancreatic Cancer Diagnosis )

Also on site :

• All crew members successfully rescued from fire at Platform Habitat off Carpinteria coast Monday
• Three men accused of kidnapping family in Perinton pleaded not guilty in court Monday
• We Thought Our Friends of 30 Years Were in the Same Financial Boat We Were. We Couldn’t Have Been More Wrong.